Optimizing the management of patients with haemophilia A and inhibitors in the era of emicizumab: Recommendations from a German expert panel.
Haemophilia : the official journal of the World Federation of Hemophilia
View this publicationHaemophilia : the official journal of the World Federation of Hemophilia
View this publicationProceedings of the National Academy of Sciences of the United States of America
View this publicationMutation research. Genetic toxicology and environmental mutagenesis
View this publicationImmunity
View this publicationFrontiers in immunology
View this publicationVascular
View this publicationJACC. Cardiovascular interventions
View this publicationJournal of the American Academy of Dermatology
View this publicationEBioMedicine
View this publicationInternational journal of nanomedicine
View this publication